Literature DB >> 24816223

Theory and practice of size exclusion chromatography for the analysis of protein aggregates.

Szabolcs Fekete1, Alain Beck2, Jean-Luc Veuthey3, Davy Guillarme3.   

Abstract

Size exclusion chromatography (SEC) is a historical technique widely employed for the detailed characterization of therapeutic proteins and can be considered as a reference and powerful technique for the qualitative and quantitative evaluation of aggregates. The main advantage of this approach is the mild mobile phase conditions that permit the characterization of proteins with minimal impact on the conformational structure and local environment. Despite the fact that the chromatographic behavior and peak shape are hardly predictable in SEC, some generic rules can be applied for SEC method development, which are described in this review. During recent years, some improvements were introduced to conventional SEC that will also be discussed. Of these new SEC characteristics, we discuss (i) the commercialization of shorter and narrower columns packed with reduced particle sizes allowing an improvement in the resolution and throughput; (ii) the possibility of combining SEC with various detectors, including refractive index (RI), ultraviolet (UV), multi-angle laser light scattering (MALLS) and viscometer (IV), for extensive characterization of protein samples and (iii) the possibility of hyphenating SEC with mass spectrometry (MS) detectors using an adapted mobile phase containing a small proportion of organic modifiers and ion-pairing reagents.
Copyright © 2014 Elsevier B.V. All rights reserved.

Keywords:  Aggregates; Biopharmaceuticals; Size exclusion chromatography; Therapeutic proteins

Mesh:

Substances:

Year:  2014        PMID: 24816223     DOI: 10.1016/j.jpba.2014.04.011

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  24 in total

1.  Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.

Authors:  Rabah Gahoual; Michaël Biacchi; Johana Chicher; Lauriane Kuhn; Philippe Hammann; Alain Beck; Emmanuelle Leize-Wagner; Yannis N François
Journal:  MAbs       Date:  2014       Impact factor: 5.857

2.  PDZ Sample Quality Assessment by Biochemical and Biophysical Characterizations.

Authors:  Célia Caillet-Saguy; Sébastien Brûlé; Nicolas Wolff; Bertrand Raynal
Journal:  Methods Mol Biol       Date:  2021

3.  Assessing and Improving Protein Sample Quality.

Authors:  Bertrand Raynal; Sébastien Brûlé; Stephan Uebel; Stefan H Knauer
Journal:  Methods Mol Biol       Date:  2021

4.  Infliximab crystal structures reveal insights into self-association.

Authors:  Thomas F Lerch; Penelope Sharpe; Stephen J Mayclin; Thomas E Edwards; Eunhee Lee; Hugh D Conlon; Sharon Polleck; Jason C Rouse; Yin Luo; Qin Zou
Journal:  MAbs       Date:  2017-04-19       Impact factor: 5.857

5.  Methods to Analyze the Redox Reactivity of Plant Proteins.

Authors:  Thualfeqar Al-Mohanna; George V Popescu; Sorina C Popescu
Journal:  Methods Mol Biol       Date:  2022

6.  Assessment of protein assembly prediction in CASP12.

Authors:  Aleix Lafita; Spencer Bliven; Andriy Kryshtafovych; Martino Bertoni; Bohdan Monastyrskyy; Jose M Duarte; Torsten Schwede; Guido Capitani
Journal:  Proteins       Date:  2017-11-08

7.  Measuring NLR Oligomerization I: Size Exclusion Chromatography, Co-immunoprecipitation, and Cross-Linking.

Authors:  Sonal Khare; Alexander D Radian; Andrea Dorfleutner; Christian Stehlik
Journal:  Methods Mol Biol       Date:  2016

Review 8.  Quality Control and Downstream Processing of Therapeutic Enzymes.

Authors:  David Gervais
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 9.  Quality assessment and optimization of purified protein samples: why and how?

Authors:  Bertrand Raynal; Pascal Lenormand; Bruno Baron; Sylviane Hoos; Patrick England
Journal:  Microb Cell Fact       Date:  2014-12-30       Impact factor: 5.328

10.  Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold.

Authors:  Alice R Mazzer; Xavier Perraud; Jennifer Halley; John O'Hara; Daniel G Bracewell
Journal:  J Chromatogr A       Date:  2015-09-02       Impact factor: 4.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.